BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 29171189)

  • 21. Nuclear PTEN interferes with binding of Ku70 at double-strand breaks through post-translational poly(ADP-ribosyl)ation.
    Guan J; Zhao Q; Mao W
    Biochim Biophys Acta; 2016 Dec; 1863(12):3106-3115. PubMed ID: 27741411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A PARP1-BRG1-SIRT1 axis promotes HR repair by reducing nucleosome density at DNA damage sites.
    Chen Y; Zhang H; Xu Z; Tang H; Geng A; Cai B; Su T; Shi J; Jiang C; Tian X; Seluanov A; Huang J; Wan X; Jiang Y; Gorbunova V; Mao Z
    Nucleic Acids Res; 2019 Sep; 47(16):8563-8580. PubMed ID: 31291457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic Lethality - Its Current Application and Potential in Oncological Treatment.
    Bortlíková L; Müller P; Vojtěšek B; Rak V; Svoboda M
    Klin Onkol; 2019; 32(Supplementum 3):19-24. PubMed ID: 31627702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA double-strand breaks repair inhibitors potentiates the combined effect of VP-16 and CDDP in human colorectal adenocarcinoma (LoVo) cells.
    Kopa P; Macieja A; Pastwa E; Majsterek I; Poplawski T
    Mol Biol Rep; 2021 Jan; 48(1):709-720. PubMed ID: 33389482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA polymerase θ (POLQ), double-strand break repair, and cancer.
    Wood RD; Doublié S
    DNA Repair (Amst); 2016 Aug; 44():22-32. PubMed ID: 27264557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone deacetylase inhibitors decrease NHEJ both by acetylation of repair factors and trapping of PARP1 at DNA double-strand breaks in chromatin.
    Robert C; Nagaria PK; Pawar N; Adewuyi A; Gojo I; Meyers DJ; Cole PA; Rassool FV
    Leuk Res; 2016 Jun; 45():14-23. PubMed ID: 27064363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitors of DNA double-strand break repair at the crossroads of cancer therapy and genome editing.
    Ray U; Raghavan SC
    Biochem Pharmacol; 2020 Dec; 182():114195. PubMed ID: 32798465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymerase θ Coordinates Multiple Intrinsic Enzymatic Activities during DNA Repair.
    Zahn KE; Jensen RB
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Main steps in DNA double-strand break repair: an introduction to homologous recombination and related processes.
    Ranjha L; Howard SM; Cejka P
    Chromosoma; 2018 Jun; 127(2):187-214. PubMed ID: 29327130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Common and unique genetic interactions of the poly(ADP-ribose) polymerases PARP1 and PARP2 with DNA double-strand break repair pathways.
    Ghosh R; Roy S; Kamyab J; Danzter F; Franco S
    DNA Repair (Amst); 2016 Sep; 45():56-62. PubMed ID: 27373144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Novel Biomarkers of Homologous Recombination Defect in DNA Repair to Predict Sensitivity of Prostate Cancer Cells to PARP-Inhibitors.
    Criscuolo D; Morra F; Giannella R; Cerrato A; Celetti A
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31242618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [From poly(ADP-ribose) discovery to PARP inhibitors in cancer therapy].
    Schreiber V; Illuzzi G; Héberlé E; Dantzer F
    Bull Cancer; 2015 Oct; 102(10):863-73. PubMed ID: 26384693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair.
    Ceccaldi R; Liu JC; Amunugama R; Hajdu I; Primack B; Petalcorin MI; O'Connor KW; Konstantinopoulos PA; Elledge SJ; Boulton SJ; Yusufzai T; D'Andrea AD
    Nature; 2015 Feb; 518(7538):258-62. PubMed ID: 25642963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive Tumors.
    Jachimowicz RD; Beleggia F; Isensee J; Velpula BB; Goergens J; Bustos MA; Doll MA; Shenoy A; Checa-Rodriguez C; Wiederstein JL; Baranes-Bachar K; Bartenhagen C; Hertwig F; Teper N; Nishi T; Schmitt A; Distelmaier F; Lüdecke HJ; Albrecht B; Krüger M; Schumacher B; Geiger T; Hoon DSB; Huertas P; Fischer M; Hucho T; Peifer M; Ziv Y; Reinhardt HC; Wieczorek D; Shiloh Y
    Cell; 2019 Jan; 176(3):505-519.e22. PubMed ID: 30612738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drugging the Cancers Addicted to DNA Repair.
    Nickoloff JA; Jones D; Lee SH; Williamson EA; Hromas R
    J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 28521333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural product β-thujaplicin inhibits homologous recombination repair and sensitizes cancer cells to radiation therapy.
    Zhang L; Peng Y; Uray IP; Shen J; Wang L; Peng X; Brown PH; Tu W; Peng G
    DNA Repair (Amst); 2017 Dec; 60():89-101. PubMed ID: 29112893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting DNA Double-Strand Break (DSB) Repair to Counteract Tumor Radio-resistance.
    Zhao Y; Chen S
    Curr Drug Targets; 2019; 20(9):891-902. PubMed ID: 30806313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel small molecule inhibitor of the DNA repair protein Ku70/80.
    Weterings E; Gallegos AC; Dominick LN; Cooke LS; Bartels TN; Vagner J; Matsunaga TO; Mahadevan D
    DNA Repair (Amst); 2016 Jul; 43():98-106. PubMed ID: 27130816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting abnormal DNA repair in therapy-resistant breast cancers.
    Tobin LA; Robert C; Nagaria P; Chumsri S; Twaddell W; Ioffe OB; Greco GE; Brodie AH; Tomkinson AE; Rassool FV
    Mol Cancer Res; 2012 Jan; 10(1):96-107. PubMed ID: 22112941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Abnormalities of DNA repair and gynecological cancers].
    Auguste A; Leary A
    Bull Cancer; 2017 Nov; 104(11):971-980. PubMed ID: 29054544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.